HomeCLINICAL TRIALS, STUDIES, REGISTRIES, DATA

CLINICAL TRIALS, STUDIES, REGISTRIES, DATA

Positive Late-breaking Clinical Trial Data for the EkoSonic™ Endovascular System Presented at VIVA21

PE remains a life-threatening and complex disease, but these results provide an opportunity to advance patient care by showcasing evidence that proves a lower drug dose and shorter infusion duration of a thrombolytic agent may result in enhanced safety and efficacy," said Keith M. Sterling, M.D., FSIR, Inova Alexandria Hospital, Alexandria, VA, study principal investigator.

Boston Scientific Announces Positive Late-Breaking Clinical Trial Data for the Ranger™ Drug-Coated Balloon

The data included two-year results from the RANGER II SFA randomized controlled trial, confirming the safety and efficacy of the Ranger DCB compared to standard percutaneous transluminal angioplasty (PTA) for the treatment of patients with peripheral artery disease (PAD) in the superficial femoral artery (SFA) and proximal popliteal artery (PPA).

Clinical Data Acquired by the PURE EP™ System Published in the Journal of Cardiac Electrophysiology

The PURE EP 2.0 study was conducted at three U.S. hospitals: Texas Cardiac Arrhythmia Institute at St. David’s Medical Center, Mayo Clinic Jacksonville, and Massachusetts General Hospital.

Actipulse Neuroscience Announces Successful Clinical Trial Using Fast Gamma Magnetic Stimulation for the Treatment of Alzheimer’s Disease

"We are extremely happy with the results from this safety trial and are eager to start the efficacy study with the hope of finding a new method to slow disease progression," said Adrien Châtillon, Chief Executive Officer and co-founder of Actipulse Neuroscience.

UltraSight Collaboration with GE Healthcare will bring Wireless Cardiac Point of Care Ultrasound to Space

The goal of this study is to demonstrate how, using the right technology, accurate, cardiac ultrasound images can be acquired anywhere, even in space, and how AI guidance has the potential to enable successful scanning with limited training.

NeuroOne Medical Technologies Corporation Announces Successful Completion of Feasibility Study for Ablation Electrode

Dr. Robert Gross of Emory says, "This pilot study will provide important data to inform the development of this technological solution that has the potential to improve treatment efficacy and patient comfort."

Medtronic Enrolls 1st Patient Completing 1st Surgical Procedure in its BRAIVE™ IDE Study

The device is Medtronic's latest innovation in the pediatric spine category, and the study's initiation reaffirms the company's commitment to continued innovation for pediatric patients.

Japanese SELUTION SLR™ Study Completes Enrollment

The study involves 133 patients across 13 centers in Japan. Its objective is to assess the safety and efficacy of SELUTION SLR for the treatment of lesions of superficial femoral arteries and/or popliteal arteries.

TheraSphere™ Y-90 Glass Microspheres Late Breaking Data

EPOCH trial represents the first positive phase 3 study for selective internal radiation therapy.
Exit mobile version